FDA Inspection 1322502 — Stephan A. Grupp, M.D., Ph.D.
The FDA completed an inspection of Stephan A. Grupp, M.D., Ph.D. on Jun 4, 2026 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 4, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Clinical Investigator (CI)